VDVIX Vanguard Developed Markets Index Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

The investment seeks to track the performance of the FTSE Developed All Cap ex U.S. Index. The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex U.S. Index, a market-capitalization-weighted index that is made up of approximately 3,957 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

The average market capitalization across the Vanguard Developed Markets Index Inv MF is 252.7B. The market cap for tickers in the group ranges from 3.51M to 674.96B. ASML holds the highest valuation in this group at 674.96B. The lowest valued company is NOVN at 3.51M.

The average weekly volume growth across all stocks in the Vanguard Developed Markets Index Inv MF was 2%. For the same stocks of the MF, the average monthly volume growth was -5% and the average quarterly volume growth was -2%